VI
BIO icon

Versor Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

Versor Investments’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,574
Closed -$1.07M – 728
2022
Q3 		$1.07M Buy
+2,574
New +$1.28M 0.06% 206
2022
Q2 		– Sell
-2,658
Closed -$1.5M – 799
2022
Q1 		$1.5M Buy
2,658
+389
+17% +$234K 0.06% 78
2021
Q4 		$1.71M Buy
2,269
+155
+7% +$116K 0.05% 60
2021
Q3 		$1.58M Sell
2,114
-47
-2% -$35.2K 0.05% 68
2021
Q2 		$1.39M Sell
2,161
-10
-0.5% -$6.09K 0.05% 60
2021
Q1 		$1.24M Buy
2,171
+1,602
+282% +$949K 0.07% 50
2020
Q4 		$332K Sell
569
-3,807
-87% -$2.17M 0.03% 59
2020
Q3 		$2.26M Buy
4,376
+1,558
+55% +$789K 0.19% 30
2020
Q2 		$1.27M Sell
2,818
-1,373
-33% -$606K 0.13% 20
2020
Q1 		$1.47M Sell
4,191
-5,609
-57% -$2.06M 0.1% 37
2019
Q4 		$3.63M Buy
9,800
+6,200
+172% +$2.19M 0.18% 43
2019
Q3 		$1.2M Buy
3,600
+1,700
+89% +$555K 0.08% 119
2019
Q2 		$594K Buy
+1,900
New +$569K 0.04% 201

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Versor Investments's BIO Position: Q4 2022 in Review

Versor Investments sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2022, closing a stake of 2,574 shares — an estimated $1.07M sold.

Versor Investments first reported a position in BIO in Q2 2019 and held it in 13 quarters. The position peaked at $3.63M in Q4 2019. 470 funds tracked by Wall St. Rank hold BIO as of Q4 2022.

  • Versor Investments reported no remaining Bio-Rad Laboratories Class A position as of Q4 2022 after selling out during the quarter.
  • Versor Investments sold 2,574 Bio-Rad Laboratories Class A shares in Q4 2022, an estimated $1.07M.
  • Versor Investments first reported a position in Bio-Rad Laboratories Class A in Q2 2019 and held it in 13 quarters.
  • Versor Investments's Bio-Rad Laboratories Class A position peaked at $3.63M in Q4 2019.
  • 470 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2022.

Based on Versor Investments's 13F filing for Q4 2022, filed 30 Jan 2023.